1. Home
  2. LFMD vs OBIO Comparison

LFMD vs OBIO Comparison

Compare LFMD & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$4.55

Market Cap

236.7M

Sector

Health Care

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.10

Market Cap

240.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
OBIO
Founded
1994
2017
Country
United States
United States
Employees
384
N/A
Industry
Medical/Nursing Services
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.7M
240.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LFMD
OBIO
Price
$4.55
$4.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$9.14
$14.25
AVG Volume (30 Days)
907.2K
228.5K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.13
EPS
N/A
N/A
Revenue
N/A
$33,482,000.00
Revenue This Year
$17.52
N/A
Revenue Next Year
$18.73
$12.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$2.60
$2.20
52 Week High
$14.43
$5.42

Technical Indicators

Market Signals
Indicator
LFMD
OBIO
Relative Strength Index (RSI) 48.50 50.18
Support Level $3.39 $3.77
Resistance Level $4.74 $4.18
Average True Range (ATR) 0.37 0.19
MACD -0.05 0.01
Stochastic Oscillator 31.44 55.26

Price Performance

Historical Comparison
LFMD
OBIO

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: